Table of Contents

• What Are Metabolic Research Peptides?
• Which Compounds Are Available in the True Peptide Labs Metabolic Category?
• What Are the Categories of Metabolic Research Peptides?
• Which Metabolic Research Peptides Are Most Studied?
• What Is the Importance of Metabolic Research Peptides in Preclinical Science?
• What Research Protocols Are Described in the Metabolic Peptide Literature?
• Are Metabolic Research Peptides Studied in Combination?
• What Dose Ranges Appear in Published Metabolic Peptide Studies?
• Have Sex-Based Differences Been Observed in Metabolic Peptide Research?
• What Adverse Events Have Been Reported in the Metabolic Peptide Research Literature?
• In What Form Do Metabolic Research Peptides Ship?
• How Are Metabolic Research Peptides Tested for Purity?
• How to Purchase Metabolic Research Peptides Online
• What Is the Difference Between Metabolic and Growth Hormone Research Peptides?

What Are Metabolic Research Peptides?

Metabolic research peptides are synthetic peptide compounds used in laboratory studies to investigate metabolic signaling pathways in animal models and in vitro systems. These compounds act on receptors such as the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon receptor (GCGR), and the amylin/calcitonin receptor complex, which are the subject of active preclinical research into insulin signaling, satiety pathways, adipocyte function, and hepatic glucose output. The class is defined by receptor target and mechanism of action, per the pharmacological classification used in reviews such as Müller et al. (2019) in Molecular Metabolism published by the German Center for Diabetes Research.

Which Compounds Are Available in the True Peptide Labs Metabolic Category?

The compounds available in the True Peptide Labs metabolic research category, organized by receptor mechanism, are listed below. Each compound links to its dedicated product page with certificate of analysis, primary literature references, and lot-specific purity data.

• GLP-1SG — GLP-1 receptor agonist, incretin-class research compound
• GLP-2TZ — GIP/GLP-1 dual receptor agonist (twincretin-class)
• GLP-3RT — GIP/GLP-1/glucagon triple receptor agonist
• Survodutide — GLP-1/glucagon dual receptor agonist
• Cagrilintide — Long-acting amylin analog
• Tesamorelin — Growth hormone-releasing hormone (GHRH) analog studied for visceral adipose endpoints
• AOD-9604 — Synthetic hGH fragment (176-191), lipolytic research compound
• 5-Amino-1MQ — Nicotinamide N-methyltransferase (NNMT) inhibitor
• SLU-PP-332 — Estrogen-related receptor (ERR) pan-agonist

Each compound ships as lyophilized powder with a lot-specific certificate of analysis. Individual product pages provide the sequence, molecular weight, purity data, and primary literature citations for that specific compound.

What Are the Categories of Metabolic Research Peptides?

The categories of metabolic research peptides, organized by receptor target and mechanism, are as follows:

1. GLP-1 receptor agonists — mono-agonist compounds targeting GLP-1R, studied for incretin signaling and satiety endpoints.
2. GIP/GLP-1 dual agonists — twincretin compounds targeting both GIPR and GLP-1R.
3. GLP-1/glucagon dual agonists — compounds targeting GLP-1R and GCGR, studied for combined incretin and energy-expenditure endpoints.
4. GIP/GLP-1/glucagon triple agonists — investigational compounds targeting all three receptors.
5. Amylin analogs and dual amylin/calcitonin agonists — compounds studied for satiety and gastric emptying endpoints.
6. Growth hormone-releasing analogs with metabolic endpoints — including Tesamorelin, studied in the literature for visceral adipose tissue endpoints.
7. Lipolytic fragment analogs — including AOD-9604, a synthetic hGH fragment (176-191) studied in adipocyte research.
8. Small-molecule metabolic modulators — including 5-Amino-1MQ (an NNMT inhibitor) and SLU-PP-332 (an ERR agonist), included in this catalog category for their metabolic pathway relevance in the published literature.

Which Metabolic Research Peptides Are Most Studied?

The metabolic research peptides with the highest publication volume in PubMed and the largest clinical trial registry footprint in ClinicalTrials.gov include GLP-1SG, GLP-2TZ-class dual agonists, GLP-3RT-class triple agonists, Survodutide, Cagrilintide, Tesamorelin, AOD-9604, 5-Amino-1MQ, and SLU-PP-332. Publication volume and citation frequency across the National Library of Medicine's PubMed database provide one measurable indicator of research interest for each compound. Individual product pages in this category link to the primary literature and analog identifiers for each specific compound.

What Is the Importance of Metabolic Research Peptides in Preclinical Science?

Metabolic research peptides are important to preclinical science because they are the primary experimental tools for probing incretin-axis signaling, adipose tissue biology, and hepatic glucose regulation in rodent, non-human primate, and cell-culture models. The 2021 review by Drucker in Cell Metabolism, published by the Lunenfeld-Tanenbaum Research Institute in Toronto, identified GLP-1 pathway compounds as central to more than 1,200 active preclinical investigations of obesity, non-alcoholic steatohepatitis (NASH), and neurodegenerative disease models. Receptor selectivity, dose-response, and combination studies conducted with these compounds inform mechanism-of-action understanding in the peer-reviewed literature.

What Research Protocols Are Described in the Metabolic Peptide Literature?

Published preclinical protocols for metabolic peptides typically describe administration schedules (single-dose pharmacokinetic runs, chronic dosing over 4–28 days), vehicle preparation (bacteriostatic water or sterile saline reconstitution), and endpoint measurements specific to each compound (body composition by EchoMRI, oral glucose tolerance tests, indirect calorimetry, terminal serum insulin and glucagon assays). Study designs vary by research question — pharmacokinetic studies, receptor binding assays (typically using HEK293 cells expressing the target receptor), and rodent metabolic phenotyping each require distinct protocols. Researchers must consult peer-reviewed methodology sections and obtain approval from their institution's IACUC or IRB before designing any in vivo study, per NIH Office of Laboratory Animal Welfare guidance.

Are Metabolic Research Peptides Studied in Combination?

Metabolic research peptides are studied in combination in the published literature, in what pharmacology reviews term co-administration or polypharmacology research. Incretin-class compounds are frequently investigated alongside amylin analogs — for example, the 2021 Phase 2 investigation of Cagrilintide co-administered with GLP-1SG, published in The Lancet, reported additive effects on body-weight endpoints in the study population. All combination research described in the primary literature is conducted in laboratory settings under approved study protocols.

What Dose Ranges Appear in Published Metabolic Peptide Studies?

Dose ranges in the published metabolic peptide literature vary substantially by compound, model system, route of administration, and endpoint. Reported ranges span, for reference: 3–30 nmol/kg subcutaneous for GLP-1 receptor agonists in murine studies; 0.5–5 mg/kg for AOD-9604 in rodent adipose research per the 2004 Metabolism study by Ng and colleagues at Monash University; and 10–100 mg/kg oral for 5-Amino-1MQ in the NNMT inhibitor literature. Model systems include murine (C57BL/6J and diet-induced obese variants), non-human primate, and in vitro (3T3-L1 adipocytes, HepG2 hepatocytes). Specific compound product pages link to the primary literature where researchers can review the exact dose ranges reported for each study. This information is provided as literature reference only and does not constitute a recommendation for use.

Have Sex-Based Differences Been Observed in Metabolic Peptide Research?

Sex-based differences have been observed in published preclinical metabolic peptide research for several compounds in this class. Studies including the 2019 Diabetologia report by Handgraaf and colleagues at the University of Geneva documented differences between male and female rodent models in adipose tissue distribution, insulin sensitivity, and GLP-1R response magnitude. Sex as a biological variable is a mandatory design consideration under NIH policy NOT-OD-15-102 (effective 2016) and remains an active area of investigation in the metabolic research literature.

What Adverse Events Have Been Reported in the Metabolic Peptide Research Literature?

The adverse events reported in the published preclinical and clinical trial literature for metabolic research peptides include gastrointestinal effects (nausea, delayed gastric emptying) in animal models, injection-site observations (erythema, transient inflammation), and, in clinical trial submissions to the FDA for compounds that have advanced to human research, dose-dependent gastrointestinal adverse events documented in the trial safety data. Some studies have found variable event rates that may be partly due to differences in titration schedule and sample size across trials. Researchers must review the full published safety data — including FDA Advisory Committee briefing documents and peer-reviewed trial results — for any specific compound before designing a study.

In What Form Do Metabolic Research Peptides Ship?

Metabolic research peptides from True Peptide Labs ship as lyophilized (freeze-dried) peptide powder in sealed sterile vials, packaged with a lot-specific certificate of analysis (COA) documenting purity by HPLC and mass by MS. Unopened vials are typically stored refrigerated at 2–8°C per the storage instructions on the COA, and reconstituted material is stored per the published stability data for the specific compound. Cold-pack shipping options are available for temperature-sensitive compounds. All orders ship from the True Peptide Labs facility in Palm Beach Gardens, Florida.

How Are Metabolic Research Peptides Tested for Purity?

Metabolic research peptides at True Peptide Labs are tested every lot by third-party ISO-accredited analytical laboratories using high-performance liquid chromatography (HPLC) for purity determination and mass spectrometry (MS) for molecular weight confirmation. Certificates of analysis are lot-specific and are available on each product page or by request. Testing methodology follows the analytical standards described in the United States Pharmacopeia (USP) general chapter <1503> for peptide characterization.

How to Purchase Metabolic Research Peptides Online

Metabolic research peptides can be purchased directly through the True Peptide Labs catalog on this page. Products are sold exclusively for research use by qualified researchers, laboratories, and institutions, and are not available for human use. All orders ship from the Palm Beach Gardens, Florida facility with standard shipping and cold-pack options for temperature-sensitive compounds. By purchasing, buyers affirm the material will not be administered to humans or animals outside of an approved research protocol reviewed by their institution's IACUC or IRB.

What Is the Difference Between Metabolic and Growth Hormone Research Peptides?

Metabolic research peptides target receptors in the incretin, glucagon, and amylin signaling pathways, while growth hormone research peptides target the growth hormone secretagogue receptor (GHSR) and the growth hormone-releasing hormone receptor (GHRHR). The two categories overlap for compounds such as Tesamorelin and AOD-9604, which act on the growth hormone axis but are studied primarily for metabolic endpoints (visceral adipose reduction, lipolysis). The dedicated growth hormone research peptides category page covers GHSR/GHRHR-selective compounds in full.